FDA Approves Sexual Desire Drug for Postmenopausal Women

By News Health
4 weeks Ago

(MedPage Today) — The FDA expanded the approval of flibanserin (Addyi), a drug that treats low sexual desire in women, to now include some postmenopausal women, drugmaker Sprout Pharmaceuticals announced on Monday.
Flibanserin is a mixed 5-HT1A…

Source link : https://www.medpagetoday.com/obgyn/menopause/119031

Author :

Publish date : 2025-12-15 22:41:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Opportunistic Cholesterol Gene Screens: Good in Theory Only?

Surgery Beats GLP-1 Drugs for Fat Loss, Muscle Retention, Study Suggests

FDA Moves to 'Get Out of the Way' of Wearables, AI in the Clinic

Health Myths Debunked; Astronaut's Medical Crisis; GLP-1 for Psoriatic Arthritis

Healthy living tips from the Gladiators

I Deserve to Feel Safe Where I Train and Learn